Transcript for Are new COVID-19 testing solutions enough?
The major developments we're tracking on this Tuesday, confirmed coronavirus cases around the world climbing to more than 18.2 million, with at least 693,000 deaths. Our death toll in this country worse than in any other nation with more than 155,000 Americans lost. With me starting us off is ABC chief medical correspondent Dr. Jen Ashton. We've been talking about increases in covid cases in the United States. Health officials, some of them saying we're losing the battle to this virus right now. There are some potential testing solutions that have just been released, what are they? I want to get to right here the Rockefeller foundation put out a 51-page revised and updated report really suggesting solutions. We hear so many people talking about problems, what I liked about this is it took a deep dive into solutions with respect to testing. We've come pretty far. As of mid-july, over 4.5 million tests per week. They're saying, it's one thing to reopen and quite another thing to remain opened. We need to get to a point where we're doing about 30 million tests per week, they're suggesting that diagnostic and screening tests be free and readily accessible and available and they're really calling for ways to develop effective testing protocols. We haven't heard a lot about that yet and they really propose some interesting solutions in this report. So, obviously, we're doing better than we were doing in April, for sure. Obviously, some say that's simply not enough. What are some of the other recommendations that they made in this report? That's really the key. They're seeing where we've come from and also where we need to go, they say what got us to 3 million test won't get us to 30 million test a week, so they're suggesting that 90% of their the current tests are lab-based right now, that's part of the problem in terms of turnaround time. There are now four screening tests available in the U.S., using tests to screen a population without symptoms and using tests to diagnose those with symptoms. And the good news is, they're pointing to the fact that saliva tests initially kind of unreliable showing more promise and can get faster results, so their solutions, part of them they propose, much more on-site point-of-care testing and rigorous protocols for screening asymptomatic people in this right now, all of our testing really is focusing on those diagnosing those that have been exposed. Lot of answers in this report. A lot of work to do, for sure, Jen, thank you so much
This transcript has been automatically generated and may not be 100% accurate.